PharmaCyte Biotech, Inc. - 8-K Filing

PharmaCyte Biotech enters into agreement with Q/C Technologies to exchange warrants for common stock and extend preferred stock maturity. (Items: 1.01 Entry into a Material Definitive Agreement, 2.01 Completion of Acquisition or Disposition of Assets, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $PMCB

Read the full article at SEC EDGAR

More Regulatory news